A recent study used multilayer omic networks to help identify molecularly distinct groups of patients with COPD in an effort to explain why patients with similar presentations might have different and distinct clinical courses.
Recommendations for interpreting spirometry severity classifications have recently been updated to include race-neutral reference equations and z scores. These researchers found that the new classification thresholds affect severity classification in the same proportion for White and Black patients with COPD and are appropriately associated with clinical risk.
Theses investigators found an increased risk for both individual and composite cardiovascular events following exacerbations of COPD, with sustained risk after 1 year regardless of severity.
William Auyeng, MD, of Standford University and the VA Hospital in Palo Alto, CA, discusses peripheral eosonophil counts, and where he hopes to see the field in the future. (1:31)
"Treating pain may require a multimodal approach," says William Auyeung, of Stanford University and the VA Hospital in Palo Alto, CA. While the goal is to avoid narcotics, there may be times when they're appropriate -- but with important stipulations. (1:54)
Data from the FDA adverse event reporting system were reviewed to investigate reports of cardiovascular adverse events observed in patients receiving treatment with long-acting muscarinic receptor antagonists.
.jpg)
.jpg)
.jpg)
